International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy

Compared with treatment options for early-stage breast cancer, few data exist regarding the optimal use of chemotherapy for metastatic breast cancer (MBC). The choice of using a combination of cytotoxic chemotherapies vs sequential single agents is controversial. At the 6th European Breast Cancer Co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2009-09, Vol.101 (17), p.1174-1181
Hauptverfasser:	Cardoso, Fatima, Bedard, Philippe L., Winer, Eric P., Pagani, Olivia, Senkus-Konefka, Elzbieta, Fallowfield, Lesley J., Kyriakides, Stella, Costa, Alberto, Cufer, Tanja, Albain, Kathy S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Anthracyclines - administration & dosage Antineoplastic Agents - administration & dosage Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biomarkers, Tumor - analysis Breast cancer Breast Neoplasms - chemistry Breast Neoplasms - drug therapy Breast Neoplasms - pathology Capecitabine Chemotherapy Comorbidity Congresses as Topic Cross-Over Studies Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Drug Administration Schedule Europe Evidence-Based Medicine Female Fluorouracil - administration & dosage Fluorouracil - analogs & derivatives Guidelines Humans International Cooperation Karnofsky Performance Status Medical treatment Menopause Patient Selection Practice Guidelines as Topic - standards Quality of Life Randomized Controlled Trials as Topic Severity of Illness Index Socioeconomic Factors Taxoids - administration & dosage Vinblastine - administration & dosage Vinblastine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!